161 related articles for article (PubMed ID: 30013756)
1. Vitamin D Status and Its Relation to Inflammatory Markers in Patients with Mild to Moderate Ulcerative Colitis.
Sharifi A; Nedjat S; Vahedi H; Veghari G; Hosseinzadeh-Attar MJ
Middle East J Dig Dis; 2018 Apr; 10(2):84-89. PubMed ID: 30013756
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial on the effect of vitamin D3 on inflammation and cathelicidin gene expression in ulcerative colitis patients.
Sharifi A; Hosseinzadeh-Attar MJ; Vahedi H; Nedjat S
Saudi J Gastroenterol; 2016; 22(4):316-23. PubMed ID: 27488327
[TBL] [Abstract][Full Text] [Related]
3. The Prevalence of Iron and Vitamin D Deficiencies in Pediatric Patients With Inflammatory Bowel Disease in Bahrain.
Isa HM; Alahmed FA; Mohamed M; Mohamed A
Cureus; 2023 Apr; 15(4):e37074. PubMed ID: 37143618
[TBL] [Abstract][Full Text] [Related]
4. The effect of vitamin D administration on inflammatory markers in patients with inflammatory bowel disease.
Jun JC; Yoon H; Choi YJ; Shin CM; Park YS; Kim N; Lee DH; Kim JS
Intest Res; 2019 Apr; 17(2):210-217. PubMed ID: 30477283
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D deficiency associated with Crohn's disease and ulcerative colitis: a meta-analysis of 55 observational studies.
Li XX; Liu Y; Luo J; Huang ZD; Zhang C; Fu Y
J Transl Med; 2019 Sep; 17(1):323. PubMed ID: 31547829
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Vitamin D on Serum Asymmetric Dimethylarginine in Patients with Mild to Moderate Ulcerative Colitis.
Javad Hosseinzadeh-Attar M; Sharifi A; Nedjat S; Mohamadkhani A; Vahedi H
Int J Vitam Nutr Res; 2020 Jan; 90(1-2):17-22. PubMed ID: 30982443
[No Abstract] [Full Text] [Related]
7. A randomized clinical trial of vitamin D
Mathur J; Naing S; Mills P; Limsui D
PeerJ; 2017; 5():e3654. PubMed ID: 28791200
[TBL] [Abstract][Full Text] [Related]
8. Influence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD Patients.
López-Muñoz P; Beltrán B; Sáez-González E; Alba A; Nos P; Iborra M
Nutrients; 2019 May; 11(5):. PubMed ID: 31083541
[TBL] [Abstract][Full Text] [Related]
9. High Prevalence of Vitamin D Deficiency among Patients with Inflammatory Bowel Disease.
Caviezel D; Maissen S; Niess JH; Kiss C; Hruz P
Inflamm Intest Dis; 2018 Jul; 2(4):200-210. PubMed ID: 30221147
[TBL] [Abstract][Full Text] [Related]
10. Influence of Severe Vitamin D Deficiency on the Clinical Course of Inflammatory Bowel Disease.
Ham NS; Hwang SW; Oh EH; Kim J; Lee HS; Park SH; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK
Dig Dis Sci; 2021 Feb; 66(2):587-596. PubMed ID: 32219610
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D Deficiency in a Portuguese Cohort of Patients with Inflammatory Bowel Disease: Prevalence and Relation to Disease Activity.
Branco JC; Cardoso MF; Anapaz V; Lourenço LC; Oliveira AM; Rodrigues CG; Santos L; Reis JA
GE Port J Gastroenterol; 2019 May; 26(3):155-162. PubMed ID: 31192283
[TBL] [Abstract][Full Text] [Related]
12. Single high-dose oral vitamin D3 treatment in New Zealand children with inflammatory bowel disease.
Martin NG; Rigterink T; Adamji M; Wall CL; Day AS
Transl Pediatr; 2019 Jan; 8(1):35-41. PubMed ID: 30881897
[TBL] [Abstract][Full Text] [Related]
13. Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases.
Hlavaty T; Krajcovicova A; Koller T; Toth J; Nevidanska M; Huorka M; Payer J
World J Gastroenterol; 2014 Nov; 20(42):15787-96. PubMed ID: 25400464
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.
Tan B; Li P; Lv H; Li Y; Wang O; Xing XP; Qian JM
J Dig Dis; 2014 Mar; 15(3):116-23. PubMed ID: 24354597
[TBL] [Abstract][Full Text] [Related]
15. Dietary vitamin D intake is not associated with 25-hydroxyvitamin D3 or parathyroid hormone in elderly subjects, whereas the calcium-to-phosphate ratio affects parathyroid hormone.
Jungert A; Neuhäuser-Berthold M
Nutr Res; 2013 Aug; 33(8):661-7. PubMed ID: 23890356
[TBL] [Abstract][Full Text] [Related]
16. Correlated expression of high-sensitivity C-reactive protein in relation to disease activity in inflammatory bowel disease: lack of differences between Crohn's disease and ulcerative colitis.
Zilberman L; Maharshak N; Arbel Y; Rogowski O; Rozenblat M; Shapira I; Berliner S; Arber N; Dotan I
Digestion; 2006; 73(4):205-9. PubMed ID: 16837810
[TBL] [Abstract][Full Text] [Related]
17. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
[TBL] [Abstract][Full Text] [Related]
19. The Association of Disease Activity, BMI and Phase Angle with Vitamin D Deficiency in Patients with IBD.
Mentella MC; Scaldaferri F; Pizzoferrato M; Gasbarrini A; Miggiano GAD
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31717788
[TBL] [Abstract][Full Text] [Related]
20. Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
Ardizzone S; Bollani S; Bettica P; Bevilacqua M; Molteni P; Bianchi Porro G
J Intern Med; 2000 Jan; 247(1):63-70. PubMed ID: 10672132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
